Bloomage Biotechnology Corporation Limited(688363)
Prior approval opinions of independent directors on relevant proposals of the 29th meeting of the first board of directors of the company
In accordance with the relevant provisions of the company law, the articles of association and the working system of independent directors, we are the independent directors of Bloomage Biotechnology Corporation Limited(688363) (hereinafter referred to as “the company”), After reviewing the proposal on renewing the company’s 2022 audit institution and the proposal on predicting the company’s daily connected transactions in 2022, which are to be submitted to the 29th meeting of the first board of directors, we hereby express our opinions as follows: 1. Proposal on renewing the company’s 2022 audit institution
Grant Thornton Certified Public Accountants (special general partnership) (hereinafter referred to as “Grant Thornton”) is one of the first audit institutions in China to obtain business qualification related to securities and futures. It is an audit institution since the company’s initial public offering and listing on the science and innovation board. In the audit process, it can fulfill its duties and follow independent, objective and fair practice standards. It is agreed to submit the proposal on the renewal of the company’s audit institution in 2022 to the 29th meeting of the first board of directors for deliberation.
2. Proposal on daily connected transactions of the company in 2022
In 2022, it is estimated that the daily related party transactions mainly include selling products, receiving labor services and renting real estate, which is in line with the actual situation of the company’s daily production and operation. The transaction is commercially reasonable. The transaction pricing follows the market-oriented principles of fairness, impartiality and fairness, does not affect the independence of the company, and does not damage the interests of the company and shareholders, especially the interests of minority shareholders, It is agreed to submit the proposal on the expected daily connected transactions of the company in 2022 to the 29th meeting of the first board of directors for deliberation. When considering this proposal, the connected directors shall withdraw from voting. (no text below)
